BNP Paribas Asset Management
RYTM icon

BNP Paribas Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

BNP Paribas Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.66M Sell
41,929
-1,943
-4% -$176K ﹤0.01% 921
2026
Q1 		$3.82M Buy
43,872
+41,457
+1,717% +$4.03M ﹤0.01% 925
2025
Q4 		$259K Buy
2,415
+1,918
+386% +$203K ﹤0.01% 1308
2025
Q3 		$50K Buy
497
+76
+18% +$7.06K ﹤0.01% 1064
2025
Q2 		$27K Buy
+421
New +$25.8K ﹤0.01% 1389

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BNP Paribas Asset Management's RYTM Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Rhythm Pharmaceuticals (RYTM) stake by 4.4% in Q2 2026, selling an estimated $176K and leaving 41,929 shares worth $4.66M. The position accounts for ﹤0.01% of the portfolio, ranked #921.

BNP Paribas Asset Management first reported a position in RYTM in Q2 2025 and has held it in 5 quarters since. 305 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • BNP Paribas Asset Management held 41,929 shares of Rhythm Pharmaceuticals worth $4.66M as of Q2 2026.
  • BNP Paribas Asset Management sold 1,943 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $176K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #921 holding.
  • BNP Paribas Asset Management first reported a position in Rhythm Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 305 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.